Your browser doesn't support javascript.
loading
Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.
Zahid, Mohammad Faizan; Moriarty, Kelsey; Dryden, Courtney; Weinberg, Olga; Asif, Misha; Ikpefan, Ruth; Anderson, Julia M; Collins, Robert H; Chung, Stephen S; Chen, Weina; Patel, Prapti A; Madanat, Yazan F.
Afiliação
  • Zahid MF; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Moriarty K; Department of Internal Medicine, Division of Hematology and Medical Oncology, Leukemia Program, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Dryden C; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Weinberg O; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Asif M; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Ikpefan R; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Anderson JM; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Collins RH; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Chung SS; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Chen W; Department of Internal Medicine, Division of Hematology and Medical Oncology, Leukemia Program, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Patel PA; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Madanat YF; Department of Internal Medicine, Division of Hematology and Medical Oncology, Leukemia Program, UT Southwestern Medical Center, Dallas, Texas, USA.
Eur J Haematol ; 111(6): 844-850, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37587783

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos